Absolute numbers among CS groups. by Eva Rydahl (6260771)

Subjects:

HSJ and controls stratified by timing for CS and parity. by Eva Rydahl (6260771)

Subjects:

Summary map of all contacts with statistically significant SVM classifications. by Alexander P. Rockhill (6053618)

“…Yellow indicates an increase in time-frequency clusters during number trials versus inter-trial intervals while blue indicates a decrease in time-frequency clusters. …”

This diagram summarizes the main steps of our study, including data sourcing from the GBD 2021 database, stratified processing by disease stage, age, and sex, application of EAPC a... by Xinyue Qi (9637055)

Subjects:

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Effects of GJE extract treatment decreased protein expression of MMP-12, α-SMA, IL-13, and TGF-β1 levels. by Natnicha Suttawong (22367172)

Patient Example. by James M. Friedman (22522150)

Subjects:

Tax1bp1-deficiency decreases the frequency of microabscess formation and lymphocyte depletion during <i>L. monocytogenes</i> infection. by Jeffrey Chin (22538086)

Inhibition of LDHA leads to decreased ATP, reduced AKT phosphorylation, and enhanced chemotherapy sensitivity to LBP in A549 and NCL-H1975 cells. by Siyu Yuan (7425719)

Subjects:

Ischemic heart disease-related mortality trends in older adult population and stratified for census regions in 1999–2020. by Fakhar Latif (19760906)

Subjects:

Ischemic heart disease-related mortality trends in older adult population and stratified for metropolitan vs. non-metropolitan in 1999–2020. by Fakhar Latif (19760906)

Subjects:

Ischemic heart disease-related mortality trends in older adult population and stratified for gender in 1999–2020. by Fakhar Latif (19760906)

Subjects:

Ischemic heart disease-related mortality trends in older adult population and stratified for older vs. young population in 1999–2020. by Fakhar Latif (19760906)

Subjects:

Deaths, overall AAMRs, and Annual Percent Change (APC) of ischemic heart diseases-related mortality in older adults in the United States, 1999 to 2020. by Fakhar Latif (19760906)

Subjects:

Ischemic heart disease-related mortality trends in older adult population and stratified for causes in 1999–2020. by Fakhar Latif (19760906)

Subjects:

Ischemic heart disease-related mortality trends in older adult population and stratified for age groups in 1999–2020. by Fakhar Latif (19760906)

Subjects:

Ischemic heart disease-related mortality trends in older adult population stratified for differential racial groups in 1999–2020. by Fakhar Latif (19760906)

Subjects:

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P_i-induced VSMCs. …”

RcbA and RcbB co-operatively decrease motility independent of CaCl₂ concentration. by Shobnom Mustaree (21728815)